NCT02247206

Brief Summary

The purpose of this research is to examine the preliminary efficacy, feasibility, and acceptability of Voice over Internet Protocol delivered behavior therapy for Tourette Syndrome through in a randomized waitlist-controlled trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Dec 2012

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 23, 2014

Completed
Last Updated

September 23, 2014

Status Verified

September 1, 2014

Enrollment Period

9 months

First QC Date

September 15, 2014

Last Update Submit

September 18, 2014

Conditions

Keywords

Tourette Syndrometic disordersbehavior therapyweb-based videoconferencingVoIP

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in Yale Global Tic Severity Scale (YGTSS) total tic severity scores at 10 weeks

    The YGTSS is a clinician-rated tic severity measure, featuring a total severity score, with a rating from 0 to 50, and independent subtotals for motor and vocal tics each with ratings from 0 to 25. It also features a tic-related 0-50 point impairment scale.

    Baseline, 10-week (post-treatment)

Secondary Outcomes (2)

  • Change from baseline on the Clinical Global Impressions-Severity scale at 10 weeks

    Baseline, 10-week (post-treatment)

  • Treatment response rate using the Clinical Global Impressions-Improvement scale at 10 weeks

    10-week (post-treatment)

Study Arms (2)

Behavior Therapy for Tics (CBIT)

EXPERIMENTAL

The child 1) learns to become more aware of any sensations, or urges that may trigger tics, and 2) learn some other behavior (competing response) to do every time he/she feels the urge to tic. The child's parent is trained to provide prompts and praise for use of the competing response. The parent and family also receive psychoeducation about tics, and learn ways to reduce the impact of environmental stimuli on tic severity. The child learns relaxation techniques to reduce stress and make it easier for him/her to resist his or her tics. Prior to treatment sessions, the parent and child spend about 10 minutes discussing with the therapist any problematic issues he/she is having. At the end of treatment sessions the child is assigned some tasks to practice prior to the next session.

Behavioral: Behavior Therapy for Tics (CBIT)

Waitlist-control Group

NO INTERVENTION

Participants in the waitlist-control group, do not receive behavior therapy for tics or any other treatment during the 10-week acute treatment period. Instead they child are placed on a waitlist to receive videoconference-delivered treatment following the end of the study period.

Interventions

CBIT is an 8-session 10-week behavioral treatment for chronic tic disorders, including Tourette Syndrome. The first two sessions are 90 minutes, with subsequent sessions lasting 60 minutes. The treatment consists of Habit Reversal Training (awareness training, competing response training, and social support), and function-based assessment to reduce the impact of environmental or other stimuli on tic severity. The treatment also consists of relaxation techniques to reduce tic-related stress and tension, and behavioral rewards to motivate treatment compliance.

Also known as: Comprehensive Behavioral Intervention for Tics (CBIT), Habit Reversal Training (HRT)
Behavior Therapy for Tics (CBIT)

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Resides in the state of Wisconsin
  • Ages 8-17
  • Meets DSM-IV-TR diagnostic criteria for Chronic Tic Disorder (CMVT or TS)
  • Clinical global Impressions - Severity Score greater than or equal to 4 (moderately ill)
  • YGTSS Total Score greater than or equal to 14 and less than 30 OR Total Score greater than or equal to 10 and less than 20 if CTD with motor tics only
  • Unmedicated or on stable medication treatment for tics, OCD, ADHD, anxiety, and/or depressive disorder for at least 6 weeks, with no planned changes for duration of study participation
  • Fluent English speaker

You may not qualify if:

  • YGTSS Total Tic Score \> 30 (for any score exceeding 30 on the YGTSS, the research team determined the appropriateness of the patient's participation in the study, taking into account the patient's global functioning)
  • WASI-Vocab subtest T-Score \< 37
  • DSM-IV substance abuse or dependence or Conduct Disorder within the past 3 months
  • Lifetime DSM-IV diagnosis of Pervasive developmental disorder, Mania, or Psychotic Disorder
  • Any serious psychiatric, psychosocial, or neurological condition requiring immediate treatment other than that provided in the current
  • Previous treatment with HRT for tics (four or more sessions)
  • Lack of a functional, and accessible home computer, and high speed (i.e., cable/DSL) internet connection
  • Refusal to sign a release of information form for the child's local primary care physician, mental health professional, or neurologist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin-Milwaukee Psychology Department

Milwaukee, Wisconsin, 53211, United States

Location

MeSH Terms

Conditions

Tourette SyndromeTic Disorders

Interventions

Behavior Therapy

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Emily J Ricketts, PhD

    University of Wisconsin, Milwaukee

    PRINCIPAL INVESTIGATOR
  • Douglas W Woods, PhD

    Texas A&M University

    STUDY DIRECTOR
  • Michael B Himle, PhD

    University of Utah

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral Student

Study Record Dates

First Submitted

September 15, 2014

First Posted

September 23, 2014

Study Start

December 1, 2012

Primary Completion

September 1, 2013

Study Completion

November 1, 2013

Last Updated

September 23, 2014

Record last verified: 2014-09

Locations